| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
BRIEF REPORT |
Obesity and Diabetes Clinical Research Section (N.P., J.C.B., E.O., A.D.S., C.B., J.K.), Phoenix Epidemiology and Clinical Research Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Department of Health and Human Services, Phoenix, Arizona 85016; and Department of Medicine and Molecular Science (T.F.), Osaka University Graduate School of Medicine, Suita, Osaka 565-0871 Japan
Address all correspondence and requests for reprints to: Nicola Pannacciulli, M.D., Ph.D., Obesity and Diabetes Clinical Research Section, Phoenix Epidemiology and Clinical Research Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Department of Health and Human Services, 4212 North 16th Street, Phoenix, Arizona 85016. E-mail: nicolap{at}mail.nih.gov.
Context: The possible role of adiponectin, a protein uniquely produced by the adipose tissue and significantly reduced in obesity and other insulin-resistant states, in the regulation of energy expenditure (EE) is still poorly understood.
Objective: The objective of the study was to investigate the relationship between total fasting plasma adiponectin concentrations and the various components of EE measured in a metabolic chamber in Pima Indians and to test whether body fat distribution may have a role in this association.
Design: This was a cross-sectional study.
Setting: The study was an inpatient clinical research unit.
Participants: Sixty nondiabetic Pima Indians (45 males and 15 females), aged 1845 yr, spanning a wide range of adiposity (body mass index 19.646.2 kg/m2) participated in the study.
Main Outcome Measures: Total fasting plasma adiponectin concentrations, EE (24-h respiratory chamber), insulin sensitivity (euglycemic-hyperisulinemic clamp), body composition (dual-energy x-ray absorptiometry), and body fat distribution (waist to thigh ratio) were the main outcome measures.
Results: Total fasting plasma adiponectin concentrations are negatively associated with sleep EE adjusted for sex, age, fat-free mass, and fat mass. This correlation is still significant, although attenuated, after inclusion of insulin-stimulated glucose disposal among the regressors and further attenuated when adjusted also for waist to thigh ratio.
Conclusions: The decrease in total fasting plasma adiponectin concentrations that accompanies fat accumulation may be a mechanism to prevent further weight gain by decreasing insulin sensitivity and increasing energy expenditure.
This article has been cited by other articles:
![]() |
C. A. Aguilar-Salinas, E. G. Garcia, L. Robles, D. Riano, D. G. Ruiz-Gomez, A. C. Garcia-Ulloa, M. A. Melgarejo, M. Zamora, L. E. Guillen-Pineda, R. Mehta, et al. High Adiponectin Concentrations Are Associated with the Metabolically Healthy Obese Phenotype J. Clin. Endocrinol. Metab., October 1, 2008; 93(10): 4075 - 4079. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |